Compare RYI & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYI | ARCT |
|---|---|---|
| Founded | 1842 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 650.0M | 194.1M |
| IPO Year | N/A | N/A |
| Metric | RYI | ARCT |
|---|---|---|
| Price | $25.43 | $6.49 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 11 |
| Target Price | $25.00 | ★ $38.67 |
| AVG Volume (30 Days) | 362.6K | ★ 794.2K |
| Earning Date | 10-28-2025 | 11-10-2025 |
| Dividend Yield | ★ 2.90% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,473,900,000.00 | $97,601,000.00 |
| Revenue This Year | $0.38 | N/A |
| Revenue Next Year | $4.72 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.18 | $5.85 |
| 52 Week High | $27.41 | $24.17 |
| Indicator | RYI | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 62.99 | 34.92 |
| Support Level | $23.57 | $6.38 |
| Resistance Level | $26.39 | $7.76 |
| Average True Range (ATR) | 0.97 | 0.43 |
| MACD | 0.18 | 0.20 |
| Stochastic Oscillator | 73.95 | 22.50 |
Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority revenue is generated from the United States.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.